A detailed history of Crescent Grove Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 2,193 shares of DXCM stock, worth $152,391. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,193
Holding current value
$152,391
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$110.31 - $140.45 $241,909 - $308,006
2,193 New
2,193 $248,000
Q2 2023

Jul 13, 2023

BUY
$112.47 - $130.98 $225,164 - $262,221
2,002 New
2,002 $257,000
Q2 2022

Jul 20, 2022

SELL
$67.99 - $132.89 $31,275 - $61,129
-460 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$129.87 - $162.82 $59,740 - $74,897
460 New
460 $247,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Crescent Grove Advisors, LLC Portfolio

Follow Crescent Grove Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.